Conditions: Non Small Cell Lung Cancer; Brain Metastases
Interventions: Drug: Icotinib; Radiation: SRS/WBRT/HA-WBRT/SMART
Sponsor: Betta Pharmaceuticals Co., Ltd.
Recruiting
Feeds
37388 items (37388 unread) in 74 feeds
Acinar Cell Carcinoma
(249 unread)
Acinic Cell Carcinoma
(163 unread)
Adenoid Cystic Carcinoma
(812 unread)
Adrenal Gland Cancer
(3080 unread)
Ampulla Of Vater
(1026 unread)
Anal Cancer
(3839 unread)
Angiosarcoma
(1177 unread)
Appendix Cancer
(509 unread)
Bile Duct Cancer
(4510 unread)
Brain and CNS
(4965 unread)
Carcinoid
(1597 unread)
Endocrine/Neuroendocrine
(4186 unread)
Gall Bladder Cancer
(1686 unread)
Hemangioendothelioma
(424 unread)
Hepatoblastoma
(568 unread)
Pancreas
(505 unread)
Phyllodes
(290 unread)
PMP and Mucinous Tumors
(360 unread)
Rhabdomyosarcoma
(1361 unread)
Sarcoma
(6081 unread)
Trial - Brain Tumor (100 unread)
-
A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy
Posted: August 15th, 2019, 2:00pm GMT
-
Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas
Posted: August 14th, 2019, 2:00pm GMT
Conditions: Brain Tumor; Glioma
Interventions: Device: Orbeye surgical videomicroscope; Drug: 5-Aminolevulinic Acid
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Olympus Corporation
Recruiting -
An Early Phase 1 Trial of Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
Posted: August 9th, 2019, 2:00pm GMT
Conditions: Glial Tumor of Brain; Diffuse Intrinsic Pontine Glioma; Glioma
Interventions: Drug: Gemcitabine; Procedure: Tumor biopsy and blood draw
Sponsors: University of Michigan Rogel Cancer Center; University of Colorado, Denver
Not yet recruiting -
Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
Posted: August 8th, 2019, 2:00pm GMT
Conditions: Glioblastoma; Medulloblastoma; Ependymoma; Diffuse Intrinsic Pontine Glioma
Interventions: Drug: Indoximod; Radiation: Partial Radiation; Radiation: Full-dose Radiation; Drug: Temozolomide; Drug: Cyclophosphamide; Drug: Etoposide; Drug: Lomustine
Sponsors: Theodore S. Johnson; Emory University
Not yet recruiting -
Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study
Posted: August 7th, 2019, 2:00pm GMT
Conditions: Brain Tumor; Brain Metastases; Brain Cancer
Intervention: Radiation: Reduced Dose SRS
Sponsor: Indiana University
Not yet recruiting -
Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
Posted: August 6th, 2019, 2:00pm GMT
Condition: Microdialysis
Intervention: Device: Intraoperative cerebral microdialysis using M dialysis 107 pump and 71 High cut-off brain microdialysis catheter
Sponsor: Mayo Clinic
Not yet recruiting -
CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma
Posted: August 6th, 2019, 2:00pm GMT
Conditions: Astrocytoma; Glioblastoma
Intervention: Drug: CC-90010
Sponsor: Celgene
Not yet recruiting -
Fluoroethyltyrosine in Detecting Tumors in Participants With Recurrent Intracranial Tumors
Posted: August 5th, 2019, 2:00pm GMT
Conditions: Intracranial Neoplasm; Low Grade Glioma; Recurrent Glioblastoma; Recurrent World Health Organization (WHO) Grade II Glioma; Recurrent WHO Grade III Glioma
Interventions: Drug: F-18 Fluoroethyltyrosine (FET); Procedure: Positron Emission Tomography (PET)
Sponsor: Thomas Hope
Recruiting -
Body Image and Self-esteem in Adolescence
Posted: August 2nd, 2019, 2:00pm GMT
Condition: Body Image
Interventions: Other: Body Image evaluation; Other: Self esteem evaluation
Sponsor: Meyer Children's Hospital
Recruiting -
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Posted: August 2nd, 2019, 2:00pm GMT
Conditions: Pituitary; Pituitary Tumor; Pituitary Carcinoma; Pituitary Cancer
Interventions: Drug: Ipilimumab; Drug: Nivolumab
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting -
Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases
Posted: August 1st, 2019, 2:00pm GMT
Condition: Brain Metastases
Intervention: Drug: Glucocorticoids
Sponsor: Medical University of Vienna
Not yet recruiting -
Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection
Posted: July 31st, 2019, 2:00pm GMT
Condition: Brain Metastases
Intervention: Device: intraoperative radiotherapy (IORT)
Sponsor: University of Louisville
Not yet recruiting -
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
Posted: July 26th, 2019, 2:00pm GMT
Condition: Brain Tumor
Intervention: Device: MRI
Sponsor: Dana-Farber Cancer Institute
Not yet recruiting -
Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
Posted: July 26th, 2019, 2:00pm GMT
Conditions: Cognitive Decline; Chemo-brain
Intervention: Drug: Memantine
Sponsors: UNC Lineberger Comprehensive Cancer Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting -
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Posted: July 24th, 2019, 2:00pm GMT
Conditions: Breast Cancer; HER2-positive Breast Cancer; Triple Negative Breast Cancer; Hormone Receptor Positive Malignant Neoplasm of Breast; Inflammatory Breast Cancer; Metastatic Breast Cancer
Intervention: Device: MRI
Sponsors: Dana-Farber Cancer Institute; Conquer Cancer Foundation
Not yet recruiting -
The Master Registry of Oncology Outcomes Associated With Testing and Treatment
Posted: July 22nd, 2019, 2:00pm GMT
Conditions: Adenocarcinoma; Adenocystic Carcinoma; Anal Cancer; Appendix Cancer; Brain Tumor; Glioblastoma; Astrocytoma; Bile Duct Cancer; Cholangiocarcinoma; Bladder Cancer; Bone Cancer; Synovial Sarcoma; Chondrosarcoma; Liposarcoma; Sarcoma, Kaposi; Sarcoma,Soft Tissue; Sarcoma; Osteosarcoma; CNS Cancer; Brain Stem Neoplasms; Breast Cancer; Cervical Cancer; Colorectal Cancer; Rectal Cancer; Colon Cancer; Esophageal Cancer; Esophagus Cancer; Cancer of Colon; Pancreatic Cancer; Cancer of Pancreas; Testis Cancer; Testicular Cancer; Ureter Cancer; Renal Cell Carcinoma; Kidney Cancer; Gestational Trophoblastic Tumor; Head and Neck Neoplasms; Parotid Tumor; Larynx Cancer; Tongue Cancer; Pharynx Cancer; Salivary Gland Cancer; Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia; Multiple Myeloma; Non Hodgkin Lymphoma; Carcinoid Tumor; Lung Cancer; Pulmonary Candidiasis; Neuroendocrine Tumors; Mesothelioma; Thyroid Cancer; Parathyroid Neoplasms; Adrenal Cancer; Small Bowel Cancer; Stomach Cancer; Liver Cancer; Hepatic Cancer; Melanoma; Skin Cancer; Unknown Primary Tumors; Uterine Cancer; Fallopian Tube Cancer; Ovarian Cancer; Prostate Cancer; Vaginal Cancer; Penile Cancer; Vulvar Cancer; Waldenstrom Macroglobulinemia; Cancer, Advanced; Thymus Cancer; Nasopharyngeal Carcinoma; Multiple Endocrine Neoplasia; Pheochromocytoma; Small Cell Carcinoma
Interventions: Diagnostic Test: Testing: Genome; Diagnostic Test: Testing: Transcriptome; Diagnostic Test: Testing: Proteome; Drug: Treatment: CAR-T
Sponsor: Taproot Health
Not yet recruiting -
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
Posted: July 17th, 2019, 2:00pm GMT
Conditions: Brain Tumor; Brain Tumor, Recurrent; Brain Tumor, Refractory; Brain Tumor, Pediatric; Medulloblastoma; Medulloblastoma Recurrent; Medulloblastoma, Non-WNT/Non-SHH; Medulloblastoma, Non-WNT/Non-SHH, Group 3; Medulloblastoma, Non-WNT/Non-SHH, Group 4; Brain Cancer; CNS Cancer; CNS Tumor; CNS Neoplasm
Interventions: Drug: Prexasertib; Drug: Cyclophosphamide; Drug: Gemcitabine; Biological: filgrastim; Biological: peg-filgrastim
Sponsors: St. Jude Children's Research Hospital; Eli Lilly and Company
Recruiting -
Pituitary Adenoma and Serum Lipid
Posted: July 16th, 2019, 2:00pm GMT
Condition: Pituitary Adenoma 1, Acth-Secreting
Intervention:
Sponsor: Shandong Provincial Hospital
Not yet recruiting -
Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors
Posted: July 15th, 2019, 2:00pm GMT
Condition: Brain Tumor, Pediatric
Intervention:
Sponsor: Capital Medical University
Recruiting -
The Impact of Endoscopic Pituitary Surgery on Nasal Function
Posted: July 15th, 2019, 2:00pm GMT
Conditions: Pituitary Tumor; Endoscopic Surgery; Quality of Life
Interventions: Procedure: Single nostril approach endoscopic transsphenoidal pituitary surgery; Procedure: Bilateral nostril approach endoscopic transsphenoidal pituitary surgery
Sponsors: Zhebao Wu; Shanghai Zhongshan Hospital; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; The First Affiliated Hospital of Nanchang University
Not yet recruiting -
Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
Posted: July 10th, 2019, 2:00pm GMT
Condition: Recurrent Glioblastoma
Interventions: Drug: Pembrolizumab; Drug: SurVaxM; Drug: Sargramostim; Drug: Montanide ISA 51
Sponsor: Manmeet Ahluwalia, MD
Not yet recruiting -
Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
Posted: July 3rd, 2019, 2:00pm GMT
Condition: Glioblastoma
Intervention: Procedure: Maximal, safe resection of brain tumour
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting -
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
Posted: July 3rd, 2019, 2:00pm GMT
Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8; High-Frequency Microsatellite Instability; Locally Advanced Urothelial Carcinoma; Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Metastatic Head and Neck Squamous Cell Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Metastatic Pancreatic Adenocarcinoma; Metastatic Urothelial Carcinoma; Mismatch Repair Deficiency; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage III Gastric Cancer AJCC v8; Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIA Gastric Cancer AJCC v8; Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIB Gastric Cancer AJCC v8; Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIC Gastric Cancer AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Pathologic Stage IV Gastric Cancer AJCC v8; Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8; PD-L1 Positive; Progressive Disease; Recurrent Head and Neck Squamous Cell Carcinoma; Refractory Lung Non-Small Cell Carcinoma; Refractory Pancreatic Adenocarcinoma; Stage II Pancreatic Cancer AJCC v8; Stage IIA Pancreatic Cancer AJCC v8; Stage IIB Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8; Unresectable Malignant Solid Neoplasm; Unresectable Melanoma; Unresectable Pancreatic Adenocarcinoma
Interventions: Biological: Pembrolizumab; Drug: Sonidegib
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Not yet recruiting -
Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost
Posted: July 3rd, 2019, 2:00pm GMT
Conditions: Primary CNS Lymphoma; Brain Lymphoma
Intervention: Radiation: A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy
Sponsor: Chang Gung Memorial Hospital
Not yet recruiting -
Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases
Posted: June 28th, 2019, 2:00pm GMT
Conditions: Brain Metastases; Melanoma; Lung Cancer; Breast Cancer
Interventions: Drug: Dexamethasone; Drug: Metformin
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Milan
Not yet recruiting -
Anti-PD-1 +/- RT for MSI-H Solid Tumors
Posted: June 27th, 2019, 2:00pm GMT
Conditions: Microsatellite Instability High; Mismatch Repair Deficiency; Colorectal Cancer
Interventions: Combination Product: RT and Anti-PD-1; Drug: Anti-PD-1
Sponsors: University of Colorado, Denver; National Cancer Institute (NCI); Cancer League of Colorado, Inc
Not yet recruiting -
Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
Posted: June 24th, 2019, 2:00pm GMT
Condition: Glioblastoma
Intervention: Drug: Sacituzumab Govitecan
Sponsors: The University of Texas Health Science Center at San Antonio; Immunomedics, Inc.
Recruiting -
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer
Posted: June 24th, 2019, 2:00pm GMT
Conditions: Small Cell Lung Cancer; Brain Metastases
Intervention: Device: Optune®-Tumor Treating Fields (TTFields)
Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University; NovoCure Ltd.
Not yet recruiting -
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
Posted: June 21st, 2019, 2:00pm GMT
Conditions: CDK Gene Mutation; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Solid Neoplasm; NTRK Family Gene Mutation; PI3K Gene Mutation; ROS1 Gene Mutation
Interventions: Drug: Abemaciclib; Drug: PI3K Inhibitor GDC-0084; Drug: Entrectinib
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Genentech, Inc.
Not yet recruiting -
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
Posted: June 19th, 2019, 2:00pm GMT
Conditions: Central Nervous System Sarcoma; Ependymoma; Glioma; Malignant Intracranial Germ Cell Tumor; Medulloblastoma; Pineoblastoma; Primary Central Nervous System Neoplasm
Interventions: Other: Placebo; Other: Questionnaire Administration; Drug: Wound Dressing Material
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting -
[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
Posted: June 18th, 2019, 2:00pm GMT
Condition: Glioma Glioblastoma Multiforme
Intervention: Drug: Axumin, Intravenous Solution
Sponsors: Seyed Ali Nabavizadeh, MD; Blue Earth Diagnostics
Not yet recruiting -
Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors
Posted: June 17th, 2019, 2:00pm GMT
Condition: Pediatric Recurrent Brain Tumor
Interventions: Biological: Personalized neoantigen DNA vaccine; Device: TDS-IM System; Procedure: Peripheral blood draw
Sponsors: Washington University School of Medicine; Children's Discovery Institute
Not yet recruiting -
Impact of nrTMS Therapy on the Progress of Neurorehabilitation
Posted: June 11th, 2019, 2:00pm GMT
Condition: Transcranial Magnetic Stimulation, Repetitive
Interventions: Device: navigated repetitive transcranial magnetic stimulation; Procedure: physical therapy
Sponsor: Technische Universität München
Recruiting -
FBY PET/CT in Patients With Brain Tumors
Posted: June 10th, 2019, 2:00pm GMT
Condition: Brain Tumor
Intervention: Diagnostic Test: FBY-PET Examination Group: Patients receive FBY-PET examination after entrance
Sponsors: Peking Union Medical College Hospital; Peking University; Beijing Cancer Hospital
Recruiting -
Study on Physical Activity's Relationship With Cancer and Cognition
Posted: June 10th, 2019, 2:00pm GMT
Conditions: Breast Cancer; Breast Neoplasm Female
Intervention: Behavioral: Walking
Sponsor: University of Nebraska
Not yet recruiting -
MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma
Posted: June 7th, 2019, 2:00pm GMT
Condition: Metastatic NRAS Melanoma
Interventions: Drug: Trametinib plus hydroxychloroquine in patients with NRAS Melanoma (Dose 1); Drug: Trametinib plus hydroxychloroquine in patients with NRAS Melanoma (Dose 2); Drug: Trametinib plus hydroxychloroquine in patients with NRAS Melanoma (Dose 3)
Sponsor: Hospices Civils de Lyon
Not yet recruiting -
Feasibility of 11C-MET PET/MRI Imaging in Pediatric Brain Fossa Tumors
Posted: June 6th, 2019, 2:00pm GMT
Condition: Posterior Brain Fossa Tumors in Children
Intervention: Procedure: 11C-MET PET/MRI
Sponsor: Hospices Civils de Lyon
Not yet recruiting -
Enhanced Recovery After Surgery Using TMS on Cerebellar Language Area for Brain Tumor Patients
Posted: June 5th, 2019, 2:00pm GMT
Conditions: Cerebellar Function; Transcranial Magnetic Stimulation; Language Disorders
Intervention: Combination Product: Transcranial magnetic stimulation
Sponsors: Huashan Hospital; Shanghai Jing'an Central Hospital; Huashan Hospital North Hospital
Recruiting -
Pediatric Long-Term Follow-up and Rollover Study
Posted: June 5th, 2019, 2:00pm GMT
Conditions: Diffuse Astrocytoma; Anaplastic Astrocytoma; Astrocytoma; Oligodendroglioma, Childhood; Anaplastic Oligodendroglioma; Glioblastoma; Pilocytic Astrocytoma; Giant Cell Astrocytoma; Pleomorphic Xanthoastrocytoma; Anaplastic Pleomorphic Xanthoastrocytoma; Angiocentric Glioma; Chordoid Glioma of Third Ventricle; Gangliocytoma; Ganglioglioma; Anaplastic Ganglioglioma; Dysplastic Gangliocytoma of Cerebrellum; Desmoplastic Infantile Astrocytoma and Ganglioglioma; Papillary Glioneuronal Tumor; Rosette-forming Glioneurona Tumor; Central Neurocytoma; Extraventricular Neurocytoma; Cerebellar Liponeurocytoma; Neurofibromatosis Type 1
Interventions: Drug: dabrafenib; Drug: trametinib
Sponsor: Novartis Pharmaceuticals
Not yet recruiting -
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
Posted: June 4th, 2019, 2:00pm GMT
Conditions: High Grade Glioma; BRAF V600E; BRAF V600K; Anaplastic Astrocytoma; Anaplastic Pleomorphic Xanthoastrocytoma; Gliosarcoma; Glioblastoma
Interventions: Drug: Encorafenib; Drug: Binimetinib; Biological: Research Bloods; Biological: Tumor Tissue
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI); Array BioPharma
Not yet recruiting -
Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma
Posted: June 4th, 2019, 2:00pm GMT
Condition: Malignant Glioma
Interventions: Biological: PVSRIPO; Drug: Atezolizumab
Sponsors: Darell D. Bigner, MD, PhD; Istari Oncology, Inc.; Genentech, Inc.
Not yet recruiting -
Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia
Posted: June 4th, 2019, 2:00pm GMT
Conditions: Pituitary Tumor; Endocrine Neoplasia; Hyperparathyroidism; Solid Tumor; Familial Tumor Syndrome
Intervention: Other: Registration of familial forms and associated neoplasia
Sponsor: Neuromed IRCCS
Not yet recruiting -
Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.
Posted: June 3rd, 2019, 2:00pm GMT
Conditions: Brain Tumor; Brain Cancer; Skull Base Tumor
Intervention:
Sponsor: Baptist Health South Florida
Recruiting -
Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade Astrocytoma
Posted: June 3rd, 2019, 2:00pm GMT
Condition: Glioma
Intervention: Biological: Blood sample
Sponsor: Assistance Publique Hopitaux De Marseille
Recruiting -
Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
Posted: June 3rd, 2019, 2:00pm GMT
Conditions: High Grade Glioma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Glioblastoma
Interventions: Drug: Regadenoson 0.05mg; Drug: Regadensoson 0.1mg; Drug: Regadensoson 0.2mg; Drug: Regadensoson 0.4mg; Drug: Regadensoson 0.7mg; Drug: Regadensoson 1.0mg; Drug: Regadensoson 1.4mg
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI)
Not yet recruiting -
Ultrasound Elastography and Ultrasentive Doppler for Surgery of Brain Tumors
Posted: May 31st, 2019, 2:00pm GMT
Condition: Brain Tumor, Primary
Intervention: Procedure: brain tumor resection
Sponsors: University Hospital, Tours; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting -
A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors
Posted: May 30th, 2019, 2:00pm GMT
Condition: Neoplasms
Intervention: Drug: BXQ-350
Sponsors: Bexion Pharmaceuticals, Inc.; CTI Clinical Trial and Consulting Services
Recruiting -
A Phase 2 Study of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases
Posted: May 30th, 2019, 2:00pm GMT
Condition: Metastatic Renal Cell Carcinoma
Intervention: Drug: Cabozantinib
Sponsor: Centre Leon Berard
Not yet recruiting -
AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
Posted: May 29th, 2019, 2:00pm GMT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: BGB 324 (before surgery); Drug: BGB 324 (after surgery)
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI)
Not yet recruiting -
Resting-State Functional MRI in Glioma Patients Before and After Surgery
Posted: May 27th, 2019, 2:00pm GMT
Conditions: Brain Mass; Glioma
Interventions: Procedure: Functional Magnetic Resonance Imaging; Procedure: Magnetic Resonance Imaging; Procedure: Resting State Functional Connectivity Magnetic Resonance Imaging
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
Posted: May 21st, 2019, 2:00pm GMT
Conditions: Glioblastoma; Astrocytoma, Grade III; Astrocytoma, Grade IV; Malignant Glioma
Intervention: Radiation: Stereotactic Radiosurgery
Sponsor: Northwell Health
Recruiting -
A Multicentric Phase II, Open-label Study Evaluating the Efficacy of the Combination of Hypofractionated Stereotactic Radiation Therapy With the Anti-PDL1 Immune Checkpoint Inhibitor Durvalumab in NSCLC Patients With 1 to 4 Brain Metastases
Posted: May 20th, 2019, 2:00pm GMT
Conditions: Brain Metastases; NSCLC
Interventions: Radiation: Radiotherapy; Combination Product: Radiotherapy + durvalumab
Sponsor: Institut Claudius Regaud
Not yet recruiting -
Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children
Posted: May 17th, 2019, 2:00pm GMT
Conditions: Brain Tumor; Ketogenic Dieting
Intervention: Other: Strict Classic Ketogenic Diet
Sponsor: Daniel Bowers
Not yet recruiting -
Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studies
Posted: May 17th, 2019, 2:00pm GMT
Condition: Cancer of Head and Neck
Intervention: Other: brain tumor-immune cells communication
Sponsor: Neuromed IRCCS
Not yet recruiting -
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
Posted: May 16th, 2019, 2:00pm GMT
Conditions: Glioma; Gliomas; High Grade Glioma; Malignant Glioma; Low Grade Glioma
Intervention: Device: 3T MRI scanner
Sponsor: National Cancer Institute (NCI)
Not yet recruiting -
Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
Posted: May 15th, 2019, 2:00pm GMT
Conditions: Glioblastoma; Brain Metastases
Intervention: Drug: Losartan
Sponsor: Kyrre Eeg Emblem
Not yet recruiting -
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
Posted: May 14th, 2019, 2:00pm GMT
Condition: Low-grade Glioma
Interventions: Device: ReMind iPad app; Device: Healthy SMS texting; Behavioral: In-person cognitive rehabilitation
Sponsors: University of California, San Francisco; University of Tilburg; University of California, Berkeley
Not yet recruiting -
The ASsessment and Physiotherapy managEment of Ataxia in Children Following Surgical Resection of Posterior Fossa Tumour
Posted: May 10th, 2019, 2:00pm GMT
Conditions: Ataxia; Posterior Fossa Tumor
Intervention: Other: Therapist
Sponsor: Alder Hey Children's NHS Foundation Trust
Recruiting -
Bioenergetic Profiling and Cognition in GBM Patients
Posted: May 7th, 2019, 2:00pm GMT
Condition: Glioblastoma
Interventions: Procedure: Cognitive Assessment; Diagnostic Test: Blood Collection; Diagnostic Test: Bioenergetic Profiling
Sponsor: Wake Forest University Health Sciences
Not yet recruiting -
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitor BMS-986158 in Pediatric Cancer
Posted: May 3rd, 2019, 2:00pm GMT
Conditions: Solid Tumor, Childhood; Lymphoma; Brain Tumor, Pediatric
Intervention: Drug: BMS-986158
Sponsors: Dana-Farber Cancer Institute; Stand Up To Cancer
Recruiting -
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Posted: May 2nd, 2019, 2:00pm GMT
Conditions: Gastric Cancer; Colorectal Cancer; Pancreatic Cancer; Sarcoma; Mesothelioma; Neuroendocrine Tumors; Squamous Cell Cancer; Merkel Cell Carcinoma; Mismatch Repair Deficiency; Microsatellite Instability
Interventions: Biological: Tumor Infiltrating Lymphocytes (TIL); Drug: Fludarabine + Cyclophosphamide combination
Sponsor: Udai Kammula
Recruiting -
A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
Posted: May 1st, 2019, 2:00pm GMT
Conditions: Breast Cancer; Brain Metastases
Intervention: Drug: Pyrotinib Plus Vinorelbine
Sponsor: Chinese Academy of Medical Sciences
Recruiting -
Nasal Irrigation Apply in Patients After Transsphenoidal Pituitary Tumor Resection
Posted: May 1st, 2019, 2:00pm GMT
Condition: Pituitary Tumor
Intervention: Behavioral: nasal irrigation
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting -
18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis
Posted: April 29th, 2019, 2:00pm GMT
Condition: Secondary Malignant Neoplasm of Brain and Cerebral Meninges
Interventions: Drug: 18F-fluciclovine; Device: PET/CT of the brain
Sponsor: Case Comprehensive Cancer Center
Recruiting -
Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
Posted: April 29th, 2019, 2:00pm GMT
Condition: Recurrent Pituitary Adenomas
Interventions: Drug: Capecitabine; Drug: Temozolomide
Sponsor: Weill Medical College of Cornell University
Recruiting -
Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma
Posted: April 25th, 2019, 2:00pm GMT
Condition: Glioma of Brain
Intervention: Drug: Topotecan
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Recruiting -
Extended Support for Persons With Pituitary Tumours After Surgery
Posted: April 25th, 2019, 2:00pm GMT
Conditions: Pituitary Tumor Benign; Surgery
Intervention: Other: person-centred practice
Sponsor: Göteborg University
Recruiting -
18F-Fluciclovine PET and Multiparametric MR Imaging
Posted: April 24th, 2019, 2:00pm GMT
Condition: Brain Tumor, Recurrent, Adult
Intervention: Drug: PET/CT with F-Fluciclovine (Axumin)
Sponsors: Loma Linda University; Blue Earth Diagnostics
Not yet recruiting -
Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas
Posted: April 24th, 2019, 2:00pm GMT
Conditions: High Grade Glioma; Brain Cancer
Intervention: Drug: Nivolumab
Sponsors: Assistance Publique - Hôpitaux de Paris; Bristol-Myers Squibb
Recruiting -
RIvoraxaban in Mitral Stenosis
Posted: April 24th, 2019, 2:00pm GMT
Conditions: Mitral Stenosis; Rheumatic Heart Disease; Atrial Fibrillation; Anticoagulant Adverse Reaction
Interventions: Drug: Rivaroxaban; Drug: Warfarin
Sponsors: Rajaie Cardiovascular Medical and Research Center; National Institute for Medical research and Development (NIMAD); Abidi Pharmaceuticals
Recruiting -
F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
Posted: April 24th, 2019, 2:00pm GMT
Condition: Glioblastoma
Interventions: Procedure: Computed Tomography; Other: Fluciclovine F18; Procedure: Positron Emission Tomography
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
Posted: April 16th, 2019, 2:00pm GMT
Conditions: Glioblastoma Multiforme; Glioma of Brain
Intervention: Biological: V-Boost
Sponsor: Immunitor LLC
Recruiting -
BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
Posted: April 15th, 2019, 2:00pm GMT
Conditions: IDH1 Mutation; IDH2 Mutation; Recurrent Glioblastoma; Recurrent WHO Grade II Glioma; Recurrent WHO Grade III Glioma
Interventions: Drug: PARP Inhibitor BGB-290; Drug: Temozolomide; Procedure: Therapeutic Conventional Surgery
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI); BeiGene
Not yet recruiting -
Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Posted: April 11th, 2019, 2:00pm GMT
Conditions: Neoplasms, Brain; Glioblastoma Multiforme; Glioblastoma of Cerebellum; Neoplasms; Astrocytoma; Astrocytoma, Cerebellar; Neuroectodermal Tumors; Neuroectodermal Tumors, Primitive; Cerebellar PNET, Childhood; Cerebellar Neoplasms; Cerebellar Neoplasms, Primary; Cerebellar Neoplasm, Malignant; Cerebellar Neoplasm Malignant Primary; Neoplasm Metastases; Neoplasm Malignant; Neoplasms, Neuroepithelial; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms, Glandular and Epithelial; Neoplasms, Nerve Tissue; Central Nervous System Neoplasms, Primary; Central Nervous System Neoplasms, Malignant; Nervous System Neoplasms; Neoplasms by Site; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Medulloblastoma Recurrent; HSV; Virus; Pediatric Brain Tumor; Nervous System Cancer; Primitive Neuroectodermal Tumor (PNET) of Cerebellum
Intervention: Biological: G207
Sponsor: University of Alabama at Birmingham
Not yet recruiting -
An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis
Posted: April 11th, 2019, 2:00pm GMT
Condition: Brain Metastases
Interventions: Drug: encorafenib; Drug: binimetinib
Sponsor: Array BioPharma
Recruiting -
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Posted: April 5th, 2019, 2:00pm GMT
Condition: Medulloblastoma, Childhood
Intervention: Drug: CX 4945
Sponsors: Pediatric Brain Tumor Consortium; St. Jude Children's Research Hospital; National Cancer Institute (NCI)
Recruiting -
Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis
Posted: April 4th, 2019, 2:00pm GMT
Condition: Melanoma With Brain Metastasis
Interventions: Device: Optune; Biological: Nivolumab; Biological: Ipilimumab
Sponsors: Washington University School of Medicine; NovoCure Ltd.
Recruiting -
Oncolytic Adenovirus DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Posted: April 1st, 2019, 2:00pm GMT
Conditions: IDH1 wt Allele; Recurrent Anaplastic Astrocytoma; Recurrent Glioblastoma; Recurrent Gliosarcoma; Recurrent Malignant Glioma
Interventions: Biological: Oncolytic Adenovirus Ad5-DNX-2401; Procedure: Therapeutic Conventional Surgery
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Posted: April 1st, 2019, 2:00pm GMT
Conditions: Cancer, All Types; Cancer of Liver; Cancer of Stomach; Cancer of Head and Neck; Cancer of Rectum; Cancer of Kidney; Cancer of Esophagus; Cancer of Colon; Cancer Skin; Cancer of Cervix; Cancer, Metastatic; Cancer of Larynx; Cancer of Neck; Cancer of Lung; Cancer of Brain and Nervous System; Cancer of Vulva, Disseminated; Cancer of Pancreas; Sarcoma; GIST; Small-cell Lung Cancer; Adenocarcinoma Lung; Cancer of Prostate; Cancer, Advanced; Adrenal Cancer; Testicular Cancer; Uterine Cancer; Bronchoalveolar Cell Lung Cancer; Cancer Unknown Primary; Glioblastoma Multiforme; Oligodendroglioma; Breast Cancer; Renal Cell Carcinoma; Hepatocellular Carcinoma; Cholangiocarcinoma; Squamous Cell Carcinoma; Transitional Cell Carcinoma; Cancer, Other; Cancer, Anal; Melanoma; Cancer, Bile Duct; Cancer, Bladder; Cancer Cords Vocal; Cancers Cell Neuroendocrine; Cancer Differentiated Poorly; Cancer, Anaplastic Thyroid
Intervention:
Sponsors: SpeciCare; Dana-Farber Cancer Institute; Kalispell Regional Medical Center; Georgia Institute of Technology; Ontario Institute for Cancer Research; SEngine Precision Medicine; Helomics
Recruiting -
PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
Posted: April 1st, 2019, 2:00pm GMT
Condition: Glioblastoma
Intervention: Drug: 5-aminolevulinic acid
Sponsor: photonamic GmbH & Co. KG
Not yet recruiting -
Fimepinostat in Treating Brain Tumors in Children and Young Adults
Posted: March 28th, 2019, 2:00pm GMT
Conditions: Diffuse Intrinsic Pontine Glioma; Recurrent Anaplastic Astrocytoma; Recurrent Glioblastoma; Recurrent Malignant Glioma; Recurrent Medulloblastoma
Interventions: Drug: Fimepinostat; Procedure: Therapeutic Conventional Surgery
Sponsors: Sabine Mueller, MD, PhD; Pacific Pediatric Neuro-Oncology Consortium; Cannonball Kids' Cancer Foundation; Curis, Inc.
Recruiting -
Circulatory Function in Laparoscopic Radical Cystectomy for Bladder Cancer
Posted: March 27th, 2019, 2:00pm GMT
Conditions: Circulatory Function; Laparoscopic Radical Cystectomy for Bladder Cancer
Intervention:
Sponsor: RenJi Hospital
Recruiting -
Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma
Posted: March 26th, 2019, 2:00pm GMT
Condition: Recurrent Adult Brain Tumor
Interventions: Drug: Nivolumab; Drug: Bevacizumab
Sponsors: Ulrik Lassen; Herlev Hospital; University of Copenhagen
Recruiting -
Intraoperative Fluorescence With Augmented Reality
Posted: March 25th, 2019, 2:00pm GMT
Conditions: Vascular; Lesion, Central Nervous System; Brain Tumor; Cerebral Aneurysm; Cerebral AVM
Interventions: Device: GLOW800; Drug: indocyanine green (ICG)
Sponsor: Cedars-Sinai Medical Center
Not yet recruiting -
MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients With Triple Negative or HER2+ MBC
Posted: March 19th, 2019, 2:00pm GMT
Conditions: Breast Neoplasm; Brain Metastases; Triple Negative Breast Cancer; HER2-positive Breast Cancer
Intervention: Diagnostic Test: MRI screening
Sponsors: Sunnybrook Health Sciences Centre; Harvard University
Recruiting -
Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
Posted: March 18th, 2019, 2:00pm GMT
Conditions: Glioma; Glioblastoma
Intervention: Device: Readiband Sleep Tracking
Sponsor: Allina Health System
Recruiting -
Epilepsy-related Brain Tumors Register
Posted: March 15th, 2019, 2:00pm GMT
Condition: Epilepsy
Intervention:
Sponsor: Groupe Hospitalier Paris Saint Joseph
Recruiting -
Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain
Posted: March 13th, 2019, 2:00pm GMT
Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Malignant Neoplasm in the Brain; Metastatic Melanoma; Pathologic Stage IV Cutaneous Melanoma AJCC v8
Interventions: Biological: Ipilimumab; Biological: Pembrolizumab
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
Promotion of Well-being of Young Adult Brain Cancer Survivors
Posted: March 12th, 2019, 2:00pm GMT
Condition: Brain Tumor, Pediatric
Intervention: Behavioral: Brief Internet-based Behavioral Activation Intervention
Sponsor: University of Wisconsin, Madison
Recruiting -
Selumetinib Versus Carboplatin/Vincristine in Treating Patients With Newly Diagnosed or Previously Untreated NF1-Associated Low-Grade Glioma
Posted: March 12th, 2019, 2:00pm GMT
Conditions: Low Grade Glioma; Neurofibromatosis Type 1; Visual Pathway Glioma
Interventions: Drug: Carboplatin; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Drug: Selumetinib; Drug: Selumetinib Sulfate; Drug: Vincristine; Drug: Vincristine Sulfate
Sponsor: National Cancer Institute (NCI)
Not yet recruiting -
LIFE - Lung Cancer, Immunotherapy, Frailty, Effect
Posted: March 12th, 2019, 2:00pm GMT
Conditions: Non-small Cell Lung Cancer; Quality of Life; Brain Metastases; Venous Thromboembolism
Interventions: Diagnostic Test: CT-scans extended; Diagnostic Test: MRI scan of the brain; Other: Prospective registration of irAEs; Behavioral: Quality of Life questionnaires
Sponsors: University of Southern Denmark; Odense University Hospital; University of Copenhagen; Odense Patient Data Explorative Network; Region of Southern Denmark
Recruiting -
Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
Posted: March 11th, 2019, 2:00pm GMT
Conditions: Glioma; Glioblastoma
Intervention: Drug: Soliramfetol
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Not yet recruiting -
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers
Posted: March 11th, 2019, 2:00pm GMT
Conditions: Advanced Malignant Neoplasm; ALK Fusion Protein Expression; ALK Gene Amplification; ALK Gene Mutation; Locally Advanced Malignant Solid Neoplasm; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Neoplasm in the Central Nervous System; Metastatic Malignant Solid Neoplasm; ROS1 Fusion Positive; ROS1 Gene Amplification; ROS1 Gene Mutation
Interventions: Drug: Brigatinib; Other: Laboratory Biomarker Analysis; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: Sameek Roychowdhury; National Cancer Institute (NCI)
Not yet recruiting -
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
Posted: March 5th, 2019, 3:00pm GMT
Condition: Metastatic Tumors
Interventions: Radiation: palliative radiotherapy; Radiation: Stereotactic ablative radiotherapy
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; Beatson Institute for Cancer Research, Scotland; The Alfred; Beacon Hospital, Ireland
Not yet recruiting -
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
Posted: March 4th, 2019, 3:00pm GMT
Conditions: Glioblastoma; Glioblastoma Multiforme; Glioblastoma Multiforme of Brain; Astrocytoma, Grade IV; Brain Tumor; Brain Cancer; Brain Neoplasms
Interventions: Procedure: Awake craniotomy; Procedure: Craniotomy under general anesthesia
Sponsors: Jasper Gerritsen; Elisabeth-TweeSteden Ziekenhuis; University Medical Center Groningen; Medical Center Haaglanden; Clinical Trial Center Erasmus MC
Recruiting -
Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
Posted: March 4th, 2019, 3:00pm GMT
Conditions: Glioblastoma Multiforme; Glioblastoma
Intervention: Drug: Carvedilol
Sponsors: West Virginia University; West Virginia Clinical and Translational Science Institute
Recruiting -
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Posted: March 1st, 2019, 3:00pm GMT
Conditions: Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Large Cell Lymphoma; Refractory Childhood Acute Lymphoblastic Leukemia; Refractory Childhood Hodgkin Lymphoma; Refractory Childhood Malignant Germ Cell Neoplasm; Recurrent Childhood Brain Tumor; Recurrent Childhood Brainstem Glioma; Recurrent Childhood Rhabdomyosarcoma; Recurrent Childhood Soft Tissue Sarcoma; Recurrent Childhood Ependymoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Gliosarcoma; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Intervention:
Sponsors: Florida International University; Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Recruiting -
Exercise and Nutrition Interventions During Chemotherapy K07
Posted: February 28th, 2019, 3:00pm GMT
Condition: Neuropathy;Peripheral
Interventions: Behavioral: EXCAP Exercise; Behavioral: Nutrition Education
Sponsors: University of Rochester; National Cancer Institute (NCI)
Not yet recruiting -
Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain
Posted: February 21st, 2019, 3:00pm GMT
Condition: Brain Cancer
Intervention: Drug: Hyperpolarized [13C]Pyruvate
Sponsor: University of Texas Southwestern Medical Center
Not yet recruiting -
Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients
Posted: February 21st, 2019, 3:00pm GMT
Condition: Glioma of Brain
Intervention:
Sponsor: Universitaire Ziekenhuizen Leuven
Recruiting